Pharmacy Council of Nigeria Rebuts Kano Task Force Allegations on Drug Trafficking
The Pharmacy Council of Nigeria (PCN) has formally challenged the Kano State Multi-Agency Task Force to provide evidence for claims that federal regulators are complicit in the distribution of illicit substances.
The Pharmacy Council of Nigeria (PCN) has issued a strong rebuttal following accusations from the Kano State Multi-Agency Task Force on Drug Abuse and Illicit Trafficking. The council, which serves as the federal regulatory body for pharmaceutical practices, has demanded that the task force chairman, Muhuyi Magaji Rimin Gado, substantiate claims that its officials are shielding drug dealers and facilitating the illegal distribution of controlled medicines.
The Nature of the Allegations
The dispute originated from a press conference held by Magaji on November 14, 2026. During the event, the task force chairman alleged that both the PCN and the National Agency for Food and Drug Administration and Control (NAFDAC) were protecting individuals involved in the illicit trade of controlled substances, specifically mentioning pregabalin. Magaji further questioned the legitimacy of a pharmaceutical outlet located at No. 10 Apple Avenue in the Sabon Gari area of Kano, alleging it served as a concealed distribution center for controlled drugs. He also suggested that certain PCN officials were personally involved in clandestine pharmaceutical operations.
PCN’s Defense and Statutory Mandate
In a statement signed by Consultant Pharmacist Hasiya Abubakar Ladan, the PCN categorically denied the allegations, labeling them as misleading and baseless. The council asserted that the registration and regulation of pharmaceutical premises are strictly governed by the Pharmacy Council of Nigeria (Establishment) Act 2022. Regarding the disputed premises on Apple Avenue, the PCN maintained that its regulations do not prohibit the establishment of pharmaceutical outlets in residential areas, provided all legal requirements are met. The council challenged Magaji to cite the specific provisions of the Land Use Act he claims were violated by the registration of that site.
The council also provided clarity on the division of labor between federal agencies, noting that while the PCN issues import licenses to pharmaceutical companies, NAFDAC is responsible for issuing product permits that specify the categories and quantities of medicines allowed for importation.
Enforcement Efforts in Kano
Addressing concerns regarding its operational capacity in the state, the PCN emphasized that its regulatory framework relies on state-level committees, which include the Director of Pharmaceutical Services from the state ministry of health. The council reported significant enforcement activity in 2026, noting that its national team inspected 11 states, including Kano. In Kano alone, the PCN stated that 2,304 outlets were inspected, resulting in 1,631 premises being sealed for regulatory violations. These figures, the council noted, are separate from routine enforcement actions carried out by its local Kano office.
Call for Evidence
The PCN has invited the task force to submit any verifiable evidence of misconduct by its officers through proper administrative channels. The council warned that making sweeping, unsubstantiated claims against public institutions could undermine the collective effort to regulate medicines and protect public health. The task force, which has reported 1,760 arrests and the seizure of over 3 million pregabalin capsules, has yet to provide public documentation to support the specific accusations against the PCN staff. The council reiterated its commitment to collaborating with relevant stakeholders to curb the unauthorized distribution of controlled medicines.
<
p class=”vbna-source-note”>Source: Daily Post Nigeria
Enjoyed this story?
Get more important stories from ViralBrief delivered directly to your inbox.
Tags: Drug Trafficking · Kano · news · Nigeria · Pharmacy Council of Nigeria · Public Health · ViralBrief

Join the conversation
No comments yet. Be the first to share a thoughtful response.